Security
Eton Pharmaceuticals, Inc. Common Stock · ETON
ETONNASDAQCommon stockCurrentCIK 1710340Updated Nov 17, 2026
ETON price & chart
Loading TradingView…
NASDAQ:ETON on TradingView ↗In the news
Eton Pharmaceuticals to Participate at 2026 Wells Fargo Healthcare Conference ↗
Recent filings
SCHEDULE 13G/A - filed by EcoR1 Capital, LLC regarding Eton Pharmaceuticals, Inc.
4 filing
144 filing
SCHEDULE 13G/A - filed by Opaleye Management Inc. regarding Eton Pharmaceuticals, Inc.
10-Q filing
Show 5 more recent filings
Results of Operations and Financial Condition
Items 2.02, 9.01
Other Events
Items 8.01, 9.01
Other Events
Items 8.01, 9.01
Entry into a Material Definitive Agreement · Completion of Acquisition or Disposition of Assets
Items 1.01, 2.01, 9.01
Other Events
Items 8.01, 9.01
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 104,510,000Source | 35,841,000Source | 115,807,000Source | 101,676,000Source | 31,823,000Source | 97,710,000Source | 84,032,000Source | 30,794,000Source | 92,114,000Source | 76,123,000Source | 31,740,000Source | 25,030,000Source |
| Property, Plant and Equipment, NetUSD | 294,000Source | 33,000Source | 352,000Source | 18,000Source | 45,000Source | 372,000Source | 22,000Source | 57,000Source | 326,000Source | 34,000Source | 58,000Source | 72,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 31,878,000Source | 5,854,000Source | 45,678,000Source | 32,879,000Source | 6,122,000Source | 43,738,000Source | 33,880,000Source | 6,388,000Source | 30,878,000Source | 34,881,000Source | 4,739,000Source | 4,754,000Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 37,121,000Source | 20,261,000Source | 26,845,000Source | 25,379,000Source | 17,694,000Source | 19,661,000Source | 17,420,000Source | 16,655,000Source | 25,942,000Source | 14,936,000Source | 21,388,000Source | 16,305,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 13,082,000Source | 5,591,000Source | 24,886,000Source | 14,453,000Source | 4,873,000Source | 13,408,000Source | 16,400,000Source | 4,240,000Source | 11,757,000Source | 5,361,000Source | 3,411,000Source | 1,852,000Source |
| Inventory, NetUSD | 16,855,000Source | 1,938,000Source | 10,143,000Source | 23,791,000Source | 2,068,000Source | 14,467,000Source | 13,621,000Source | 2,318,000Source | 15,419,000Source | 15,232,000Source | 911,000Source | 557,000Source |
| Assets, CurrentUSD | 72,000,000Source | 29,749,000Source | 68,599,000Source | 68,443,000Source | 25,434,000Source | 53,245,000Source | 49,960,000Source | 24,263,000Source | 60,581,000Source | 41,021,000Source | 26,839,000Source | 20,004,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 4,942,000Source | 1,959,000Source | 6,725,000Source | 4,820,000Source | 799,000Source | 5,709,000Source | 2,519,000Source | 1,050,000Source | 7,463,000Source | 5,492,000Source | 1,129,000Source | 1,290,000Source |
| Operating Lease, Right-of-Use AssetUSD | 319,000Source | 193,000Source | 849,000Source | 333,000Source | 210,000Source | 301,000Source | 158,000Source | 74,000Source | 310,000Source | 175,000Source | 92,000Source | 188,000Source |
| Other Assets, NoncurrentUSD | 19,000Source | 12,000Source | 64,000Source | 12,000Source | 12,000Source | 54,000Source | 12,000Source | 12,000Source | 19,000Source | 12,000Source | 12,000Source | 12,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 81,384,000Source | 19,860,000Source | 69,222,000Source | 77,715,000Source | 18,361,000Source | 67,095,000Source | 59,582,000Source | 15,300,000Source | 65,960,000Source | 51,695,000Source | 16,263,000Source | 11,952,000Source |
| Stockholders’ equity: | ||||||||||||
| Common Stock, Value, IssuedUSD | 27,000Source | 26,000Source | 28,000Source | 27,000Source | 26,000Source | 27,000Source | 27,000Source | 26,000Source | 27,000Source | 27,000Source | 26,000Source | 25,000Source |
| Retained Earnings (Accumulated Deficit)USD | -113,977,000Source | -107,295,000Source | -99,362,000Source | -112,050,000Source | -107,922,000Source | -110,940,000Source | -109,465,000Source | -104,881,000Source | -112,494,000Source | -107,893,000Source | -104,070,000Source | -103,134,000Source |
| Stockholders' Equity Attributable to ParentUSD | 23,126,000Source | 15,981,000Source | 46,585,000Source | 23,961,000Source | 13,462,000Source | 30,615,000Source | 24,450,000Source | 15,494,000Source | 26,154,000Source | 24,428,000Source | 15,477,000Source | 13,078,000Source |
| Additional Paid in Capital, Common StockUSD | — | 123,250,000Source | 145,919,000Source | — | 121,358,000Source | 141,528,000Source | 133,888,000Source | 120,349,000Source | 138,621,000Source | 132,294,000Source | 119,521,000Source | 116,187,000Source |
| Liabilities and EquityUSD | 104,510,000Source | 35,841,000Source | 115,807,000Source | 101,676,000Source | 31,823,000Source | 97,710,000Source | 84,032,000Source | 30,794,000Source | 92,114,000Source | 76,123,000Source | 31,740,000Source | 25,030,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 44,183,000Source | 19,734,000Source | 45,124,000Source | 38,596,000Source | 18,216,000Source | 44,179,000Source | 25,350,000Source | 15,300,000Source | 38,490,000Source | 19,947,000Source | 16,241,000Source | 6,461,000Source |
| Operating Lease, Liability, CurrentUSD | 30,000Source | 75,000Source | 239,000Source | 23,000Source | 74,000Source | 75,000Source | 77,000Source | 87,000Source | 65,000Source | 76,000Source | — | 75,000Source |
| Accounts Payable, CurrentUSD | 14,259,000Source | 2,684,000Source | 14,405,000Source | 12,142,000Source | 2,133,000Source | 13,485,000Source | 4,872,000Source | 2,263,000Source | 10,976,000Source | 4,167,000Source | 1,848,000Source | 1,766,000Source |
| Operating Lease, Liability, NoncurrentUSD | 480,000Source | 126,000Source | 1,083,000Source | 492,000Source | 145,000Source | 440,000Source | 87,000Source | 0Source | 460,000Source | 107,000Source | 22,000Source | 107,000Source |
| Other Liabilities, NoncurrentUSD | 3,942,000Source | — | 3,937,000Source | 4,269,000Source | — | 3,537,000Source | 4,153,000Source | — | 5,241,000Source | 1,830,000Source | — | — |
| Additional Financial Items | ||||||||||||
| Accrued Liabilities, CurrentUSD | 9,117,000Source | — | 10,925,000Source | 7,459,000Source | 11,425,000Source | 7,746,000Source | 7,541,000Source | 8,017,000Source | 9,408,000Source | 8,914,000Source | 9,013,000Source | 3,662,000Source |
| Deferred Tax Liabilities, NetUSD | — | — | — | — | — | — | — | — | 0Source | 0Source | — | — |
| Long-term Debt, Current MaturitiesUSD | — | 4,125,000Source | — | — | 4,658,000Source | — | — | 5,020,000Source | 8,789,000Source | 0Source | 5,380,000Source | 1,033,000Source |
| Long-term Debt, Excluding Current MaturitiesUSD | 27,591,000Source | — | 19,078,000Source | 27,409,000Source | — | 18,939,000Source | — | — | 21,769,000Source | — | — | — |
| Additional Paid in Capital | —Source | — | — | —Source | — | — | — | — | — | — | — | — |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | — | — | — | — | 1,131,000Source | 1,013,000Source | 4,044,000Source | 1,146,000Source | 901,000Source | 66,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 1,518,000Source | 1,200,000Source | 5,512,000Source | 3,165,000Source | 3,137,000Source | 4,218,000Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | 1,651,000Source | 11,039,000Source | 6,396,000Source | 3,118,000Source | 1,559,000Source | -3,619,000Source |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | -1,406,000Source | -358,000Source | 5,876,000Source | 1,310,000Source | 354,000Source | 7,000Source |
| Increase (Decrease) in Accounts PayableUSD | — | — | — | — | — | — | 2,508,000Source | 705,000Source | 6,808,000Source | 2,318,000Source | 53,000Source | -8,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | 7,405,000Source | 2,090,000Source | 10,524,000Source | 969,000Source | 6,815,000Source | 4,821,000Source |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -15,075,000Source | 0Source | -333,000Source | -40,014,000Source | -775,000Source | -2,788,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 75,000Source | 0Source | 333,000Source | 26,000Source | 0Source | 38,000Source |
| Cash flows from financing activities: | ||||||||||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | — | — | — | — | — | — | — | — | 0Source | 0Source | — | — |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 1,389,000Source | 394,000Source | 815,000Source | 32,593,000Source | -957,000Source | -134,000Source |
| Repayments of Long-term DebtUSD | — | — | — | — | — | — | — | 0Source | 0Source | 1,155,000Source | — | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | -6,281,000Source | 2,484,000Source | 11,006,000Source | -6,452,000Source | 5,083,000Source | 1,899,000Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | 881,000Source | 642,000Source | 3,325,000Source | 665,000Source | 842,000Source | 730,000Source |
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | 37,000Source | 8,000Source | 118,000Source | 82,000Source | 247,000Source | — |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | — | — | — | — | 1,518,000Source | 1,200,000Source | 5,512,000Source | 3,165,000Source | 3,137,000Source | — |
| Amortization of Intangible AssetsUSD | — | — | — | — | — | — | 1,109,000Source | 1,001,000Source | 4,003,000Source | 1,096,000Source | 790,000Source | 1,617,000Source |
| DepreciationUSD | — | — | — | — | — | — | 22,000Source | 12,000Source | 41,000Source | 50,000Source | 44,000Source | — |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | — | — | — | — | — | — | — | — | — | — | 0Source | — |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | — | — | — | — | — | — | — | — | 0Source | — |
| General and Administrative ExpenseUSD | — | — | 8,106,000Source | 5,288,000Source | 11,626,000Source | 9,687,000Source | 10,446,000Source | 9,170,000Source | 35,819,000Source | 22,753,000Source | 18,931,000Source | 18,582,000Source |
| Income Tax Expense (Benefit)USD | — | — | -28,000Source | -126,000Source | 140,000Source | 66,000Source | 20,000Source | 74,000Source | 43,000Source | 15,000Source | 247,000Source | — |
| Inventory Write-downUSD | — | — | — | — | — | — | 227,000Source | 110,000Source | 594,000Source | — | — | 62,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -1,927,000Source | 627,000Source | 11,578,000Source | -2,585,000Source | 1,554,000Source | -1,572,000Source | -4,601,000Source | -3,823,000Source | -936,000Source | -9,021,000Source |
| Nonoperating Income (Expense)USD | — | — | — | -8,000Source | — | — | — | — | -3,714,000Source | -1,211,000Source | 503,000Source | -761,000Source |
| Operating ExpensesUSD | — | — | 9,218,000Source | 5,793,000Source | 12,619,000Source | 13,399,000Source | 12,321,000Source | 10,331,000Source | 43,584,000Source | 26,008,000Source | 22,253,000Source | 22,578,000Source |
| Operating Lease, ExpenseUSD | — | — | — | — | — | — | — | — | — | — | 77,000Source | 87,000Source |
| Proceeds from Issuance of Long-term DebtUSD | — | — | — | — | — | — | — | — | 0Source | 25,309,000Source | — | — |
| Proceeds from Stock Options ExercisedUSD | — | — | — | — | — | — | — | 394,000Source | 598,000Source | 1,191,000Source | 149,000Source | 251,000Source |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 22,459,000Source | 10,324,000Source | 37,589,000Source | 18,928,000Source | 24,266,000Source | 17,282,000Source | 79,950,000Source | 39,011,000Source | 31,642,000Source | 21,251,000Source |
| Cost of RevenueUSD | — | — | 14,604,000Source | 4,022,000Source | 12,176,000Source | 7,004,000Source | 9,531,000Source | 7,421,000Source | 37,210,000Source | 15,600,000Source | 10,581,000Source | 6,933,000Source |
| Operating Income (Loss)USD | — | — | -1,363,000Source | 509,000Source | 12,794,000Source | -1,475,000Source | 2,414,000Source | -470,000Source | -844,000Source | -2,597,000Source | -1,192,000Source | -8,260,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | -1,955,000Source | 501,000Source | 11,718,000Source | -2,519,000Source | 1,574,000Source | -1,498,000Source | -4,558,000Source | -3,808,000Source | -689,000Source | -9,021,000Source |
| Income Tax Expense (Benefit)USD | — | — | -28,000Source | -126,000Source | 140,000Source | 66,000Source | 20,000Source | 74,000Source | 43,000Source | 15,000Source | 247,000Source | — |
| Net Income (Loss) Attributable to ParentUSD | — | — | -1,927,000Source | 627,000Source | 11,578,000Source | -2,585,000Source | 1,554,000Source | -1,572,000Source | -4,601,000Source | -3,823,000Source | -936,000Source | -9,021,000Source |
| Earnings Per Share, BasicUSD per share | — | — | -0.07Source | 0.02Source | 0.42Source | -0.1Source | 0.06Source | -0.06Source | -0.17Source | -0.15Source | -0.04Source | -0.36Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 26,893,000Source | 25,900,000Source | 27,642,000Source | 26,893,000Source | 27,285,236Source | 26,886,000Source | 26,907,725Source | 25,895,086Source | 25,645,366Source | 25,145,657Source |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | — | — | — | — | 1,109,000Source | 1,001,000Source | 4,003,000Source | 1,096,000Source | 790,000Source | 1,617,000Source |
| Depreciation, Depletion and Amortization, NonproductionUSD | — | — | — | — | — | — | 1,131,000Source | 1,013,000Source | 4,044,000Source | 1,146,000Source | 901,000Source | 1,774,000Source |
| General and Administrative ExpenseUSD | — | — | 8,106,000Source | 5,288,000Source | 11,626,000Source | 9,687,000Source | 10,446,000Source | 9,170,000Source | 35,819,000Source | 22,753,000Source | 18,931,000Source | 18,582,000Source |
| Gross ProfitUSD | — | — | 7,855,000Source | 6,302,000Source | 25,413,000Source | 11,924,000Source | 14,735,000Source | 9,861,000Source | 42,740,000Source | 23,411,000Source | 21,061,000Source | 14,318,000Source |
| Interest ExpenseUSD | — | — | 1,212,000Source | 211,000Source | — | — | 1,136,000Source | 1,163,000Source | — | — | 1,060,000Source | 955,000Source |
| Interest Expense, DebtUSD | — | — | — | — | — | — | — | — | 4,781,000Source | 2,005,000Source | 1,023,000Source | — |
| Nonoperating Income (Expense)USD | — | — | — | -8,000Source | — | — | — | — | -3,714,000Source | -1,211,000Source | 503,000Source | -761,000Source |
| Operating ExpensesUSD | — | — | 9,218,000Source | 5,793,000Source | 12,619,000Source | 13,399,000Source | 12,321,000Source | 10,331,000Source | 43,584,000Source | 26,008,000Source | 22,253,000Source | 22,578,000Source |
| Operating Lease, ExpenseUSD | — | — | — | — | — | — | — | — | — | — | 77,000Source | 87,000Source |
| Research and Development ExpenseUSD | — | — | 1,112,000Source | 505,000Source | 993,000Source | 3,712,000Source | 1,875,000Source | 1,161,000Source | 7,765,000Source | 3,255,000Source | 3,322,000Source | 3,996,000Source |
| Earnings Per Share, Diluted | — | — | —Source | —Source | —Source | —Source | —Source | —Source | — | — | — | — |
| Weighted Average Number of Shares Outstanding, Diluted | — | — | —Source | —Source | —Source | —Source | —Source | —Source | — | — | — | — |
| Interest Income (Expense), Nonoperating, Net | — | — | —Source | —Source | —Source | —Source | —Source | —Source | — | — | — | — |
Filing attachments
ex991.htm · SCHEDULE 13G/A · 2026-11-16
EXHIBIT 99.1 AGREEMENT REGARDING JOINT FILING OF STATEMENT ON SCHEDULE 13D OR 13G The undersigned agree to file jointly with the Securities and Exchange Commission (the “SEC”) any and all statements on Schedule 13D or Schedule 13G or Forms 3, 4 or 5(and any amendments or supplements thereto) required under section 13(d) and 16(a) of the Securities Exchange Act of 1934, as amended, in connection with purchases by the undersigned of the securities of any issuer. For that purpose, the undersigne…
Read attachment ↗ex99-1.htm · SCHEDULE 13G/A · 2026-11-06
Exhibit 99.1 JOINT FILING AGREEMENT This Joint Filing Agreement, dated as of November 6, 2026, is by and among Opaleye Management Inc., Opaleye, L.P. and James Silverman (collectively, the “Filers”). Each of the Filers may be required to file with the United States Securities and Exchange Commission a statement on Schedule 13D and/or 13G with respect to shares of Common Stock of Eton Pharmaceuticals, Inc. beneficially owned by them from time to time. Pursuant to and in accordance with Rule 1…
Read attachment ↗